Search Results

There are 3384 results for: content related to: A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

  1. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children

    Intervention Review

    The Cochrane Library

    Bhupendrasinh F Chauhan and Francine M Ducharme

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD002314.pub3

  2. Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 2, August 2010, Pages: 223–230, T Karonen, A Filppula, J Laitila, M Niemi, P J Neuvonen and J T Backman

    Version of Record online : 30 JUN 2010, DOI: 10.1038/clpt.2010.73

  3. Clinical efficacy of montelukast in adults and children

    Clinical & Experimental Allergy Reviews

    Volume 1, Issue 3, November 2001, Pages: 264–273, T. F. Reiss, B. Knorr, K. Malmstrom, G. Noonan and S. Lu

    Version of Record online : 7 MAY 2002, DOI: 10.1046/j.1472-9725.2001.t01-1-00012.x

  4. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

    Clinical & Experimental Allergy

    Volume 31, Issue 1, January 2001, Pages: 77–87, W. Storms, T. M. Michele, B. Knorr, G. Noonan, G. Shapiro, J. Zhang, S. Shingo and T. F. Reiss

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2222.2001.00969.x

  5. You have free access to this content
    CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast

    British Journal of Clinical Pharmacology

    Volume 73, Issue 2, February 2012, Pages: 257–267, Tiina Karonen, Pertti J. Neuvonen and Janne T. Backman

    Version of Record online : 6 JAN 2012, DOI: 10.1111/j.1365-2125.2011.04086.x

  6. Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis

    The Journal of Clinical Pharmacology

    Volume 48, Issue 4, April 2008, Pages: 502–511, Dr Gregory L. Kearns, Dr Susan Lu, Dr Lata Maganti, Dr Xiujiang (Susie) Li, Dr Elizabeth Migoya, Ms Tuli Ahmed, Dr Barbara Knorr and Dr Theodore F. Reiss

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008314251

  7. Effect of Citrus Juice and SLCO2B1 Genotype on the Pharmacokinetics of Montelukast

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 751–760, Dr E. B. Mougey, Dr J. E. Lang, Ms X. Wen and Dr J. J. Lima

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010374472

  8. You have free access to this content
    Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism

    British Journal of Pharmacology

    Volume 156, Issue 1, January 2009, Pages: 105–115, Ronald Anderson, Annette J Theron, Cornelia M Gravett, Helen C Steel, Gregory R Tintinger and Charles Feldman

    Version of Record online : 5 DEC 2008, DOI: 10.1111/j.1476-5381.2008.00012.x

  9. The Targeted Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions

    The Journal of Clinical Pharmacology

    Volume 49, Issue 4, April 2009, Pages: 389–397, Dr Gabriele M. Böhmer, Dr Nassr Nassr, Marcus Wenger, Dr Andreas Hünnemeyer, Gezim Lahu, Dr Silke Templin, Dr Christoph H. Gleiter and Dr Robert Hermann

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008330980

  10. Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future

    Diseases of the Esophagus

    Volume 24, Issue 4, May 2011, Pages: 229–234, J. Stumphy, D. Al-Zubeidi, L. Guerin, F. Mitros and R. Rahhal

    Version of Record online : 12 NOV 2010, DOI: 10.1111/j.1442-2050.2010.01134.x

  11. Pharmacokinetics and Safety of Montelukast in Children Aged 3 to 6 Months

    The Journal of Clinical Pharmacology

    Volume 46, Issue 6, June 2006, Pages: 620–627, Dr Barbara Knorr, Dr Lata Maganti, Dr Rohini Ramakrishnan, Dr Carol A. Tozzi, Dr Elizabeth Migoya and Dr Gregory Kearns

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006288324

  12. Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide

    Clinical Pharmacology & Therapeutics

    Volume 79, Issue 3, March 2006, Pages: 231–242, Lauri I. Kajosaari, Mikko Niemi, Janne T. Backman and Pertti J. Neuvonen

    Version of Record online : 7 FEB 2006, DOI: 10.1016/j.clpt.2005.11.002

  13. You have free access to this content
    Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation

    British Journal of Pharmacology

    Volume 160, Issue 6, July 2010, Pages: 1399–1407, K Takeda, Y Shiraishi, S Matsubara, N Miyahara, H Matsuda, M Okamoto, A Joetham and EW Gelfand

    Version of Record online : 14 APR 2010, DOI: 10.1111/j.1476-5381.2010.00797.x

  14. Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing

    Pediatric Allergy and Immunology

    Volume 25, Issue 2, March 2014, Pages: 143–150, Wan-Sheng Peng, Xin Chen, Xiao-Yun Yang and En-Mei Liu

    Version of Record online : 7 OCT 2013, DOI: 10.1111/pai.12124

  15. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma

    Intervention Review

    The Cochrane Library

    Francine M Ducharme

    Published Online : 26 JAN 2004, DOI: 10.1002/14651858.CD003133.pub2

  16. Clinical pharmacology of montelukast

    Clinical & Experimental Allergy Reviews

    Volume 1, Issue 3, November 2001, Pages: 254–260, B. Knorr, S. Holland, J. Schwartz, J. Douglas Rogers and T. F. Reiss

    Version of Record online : 7 MAY 2002, DOI: 10.1046/j.1472-9725.2001.t01-1-00011.x

  17. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy

    Pediatric Allergy and Immunology

    Volume 17, Issue 8, December 2006, Pages: 620–628, Vasilisa Sazonov-Kocevar, Laurent Laforest, Noemie Travier, Donald D. Yin and Eric Van Ganse

    Version of Record online : 24 OCT 2006, DOI: 10.1111/j.1399-3038.2006.00459.x

  18. Pharmacokinetics of Montelukast in Asthmatic Patients 6 to 24 Months Old

    The Journal of Clinical Pharmacology

    Volume 44, Issue 5, May 2004, Pages: 487–494, Dr Elizabeth Migoya, Dr Gregory L. Kearns, Dr Alan Hartford, Dr Jamie Zhao, Dr Janet van Adelsberg, Dr Carol A. Tozzi, Dr Barbara Knorr and Dr Paul Deutsch

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004264970

  19. Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans

    The Journal of Clinical Pharmacology

    Volume 53, Issue 11, November 2013, Pages: 1186–1193, Kyoung-Ah Kim, Hye-Mi Lee, Hyun-Jin Joo, In-Bae Park and Ji-Young Park

    Version of Record online : 23 AUG 2013, DOI: 10.1002/jcph.144

  20. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 4, April 2011, Pages: 550–557, Rui Zhao, Wen-Zhen Shi, Yong-Mei Zhang, San-Hua Fang and Er-Qing Wei

    Version of Record online : 1 MAR 2011, DOI: 10.1111/j.2042-7158.2010.01238.x